Naprobin 50mg Injection
Marketer
Miracalus Pharma Pvt Ltd
Salt Composition
Fludarabine (50mg)
Overview Naprobin 50mg Injection
Chronic lymphocytic leukemia (CLL) is treated with the intravenous medication, Leukoject 50mg. This injection, administered under medical supervision, may also be prescribed for other conditions at the physician's discretion. It's often part of a broader chemotherapy regimen. Dosage and frequency are determined by your doctor based on your specific needs and may vary. Precise adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe complications. While therapeutic effects might not be immediately apparent (weeks or months may pass), discontinue use only under your physician's guidance. Common side effects include nausea, vomiting, diarrhea, headache, fatigue, fever, and cough. Leukoject 50mg can decrease blood cell counts (white and red), raising infection risk. Regular blood tests to monitor blood cell levels, along with heart, liver function, and uric acid levels are necessary. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or if you're taking anti-infectives, before starting treatment. Interactions with other medications are possible; disclose all current medications. Leukoject 50mg is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout the treatment period.
Uses of Naprobin 50mg Injection
Chronic lymphocytic leukemia, a type of blood malignancy
Major Benefits of Naprobin 50mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Naprobin 50mg Injection:
- Increased risk of infection
- Vomiting
- Weakness
- Nausea
- Fatigue
- Fever
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Cough
How to use Naprobin 50mg Injection:
Administering this medication will be handled by your physician or their qualified nurse; self-medication is strictly prohibited.
How Naprobin 50mg Injection works:
Naprobin 50mg Injection is a cancer treatment that inhibits the development of cancerous blood cells. Its mechanism of action involves disrupting the genetic material (DNA and RNA) within these cells, thereby halting their proliferation and ultimately causing their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Naprobin 50mg Injection is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Naprobin 50mg Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Naprobin 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Administering Naprobin 50mg Injection may induce adverse reactions impacting driving aptitude. Fatigue, weakness, visual disturbances, confusion, agitation, or convulsions are potential side effects during Naprobin 50mg Injection therapy, potentially compromising driving safety.
KidneyCAUTION
Patients with kidney impairment should use Naprobin 50mg Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Naprobin 50mg Injection; a physician's consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when administering Naprobin 50mg Injection. Dosage modification of Naprobin 50mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Naprobin 50mg Injection :
NA
Facts to Know About Naprobin 50mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Purine nucleoside analogs |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Metabolic Inhibitors |
3,018 People bought this recently